Please Note - Streaming News is only available to subscribers to the Active Level and above
Director Deals - (GSK)
BFN
Hal Barron, Executive Director, has re-invested 854 shares in the company on the 16th April 2024 at a price of $20.40. The Director now holds 642,587 shares.
Story provided by StockMarketWire.com
Director deals data provided by www.sharesmagazine.co.uk
